ENTRY       D01370                      Drug
NAME        Cladribine (JAN/USP/INN);
            Leustatin (TN);
            Mavenclad (TN)
PRODUCT     MAVENCLAD (EMD Serono)
  GENERIC   CLADRIBINE (Fresenius Kabi USA)
            CLADRIBINE (Hikma Pharmaceuticals USA)
            CLADRIBINE (Hisun Pharmaceuticals USA)
            CLADRIBINE (Hisun Pharmaceuticals USA)
FORMULA     C10H12ClN5O3
EXACT_MASS  285.0629
MOL_WEIGHT  285.687
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
REMARK      Therapeutic category: 4291
            ATC code: L01BB04 L04AA40
            Product: D01370<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Hairy-cell leukemia [DS:H00006]
            Multiple sclerosis [DS:H01490]
TARGET      RRM1 [HSA:6240] [KO:K10807]
            DNA polymerase
  PATHWAY   hsa00230(6240)  Purine metabolism
            hsa00240(6240)  Pyrimidine metabolism
INTERACTION  
STR_MAP     map07041  Antineoplastics - antimetabolic agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BB Purine analogues
                 L01BB04 Cladribine
                  D01370  Cladribine (JAN/USP/INN) &lt;JP/US&gt;
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA40 Cladribine
                  D01370  Cladribine (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Cladribine
                D01370  Cladribine (JAN/USP/INN)
             Central Nervous System Agents
              Multiple Sclerosis Agents
               Cladribine
                D01370  Cladribine (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D01370  Cladribine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                D01370  Cladribine
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D01370  Cladribine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Ribonucleoside-diphosphate reductase
                RRM1
                 D01370  Cladribine (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01370
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01370
DBLINKS     CAS: 4291-63-8
            PubChem: 7848433
            ChEBI: 567361
            PDB-CCD: CL9
            LigandBox: D01370
            NIKKAJI: J446.344G
ATOM        19
            1   C1y C    13.2977  -19.5392
            2   C1x C    14.6838  -19.5392
            3   C1y C    15.1121  -18.2209
            4   O2x O    13.9907  -17.4062
            5   C1y C    12.8694  -18.2209
            6   N5x N    17.5130  -19.6070
            7   C8y C    17.5130  -18.2209
            8   N4y N    16.3126  -17.5278
            9   C1b C    11.6689  -17.5278
            10  O1a O    10.4685  -18.2209
            11  O1a O    12.4829  -20.6606
            12  C8y C    18.7133  -20.3000
            13  N5x N    19.9138  -19.6070
            14  C8y C    19.9138  -18.2209
            15  C8y C    18.7133  -17.5278
            16  C8x C    16.7284  -16.1436
            17  N5x N    18.2975  -16.1432
            18  X   Cl   18.7133  -21.6877
            19  N1a N    21.1159  -17.5266
BOND        21
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     6   7 1
            7     7   8 1
            8     3   8 1 #Up
            9     5   9 1 #Up
            10    9  10 1
            11    1  11 1 #Down
            12    6  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16    7  15 2
            17    8  16 1
            18   15  17 1
            19   16  17 2
            20   12  18 1
            21   14  19 1
///
